- Release Date: 18/08/25 15:54
- Summary: Notice of Investor/Analyst Briefing 2025 Full Year Result
- Price Sensitive: No
- Download Document 145.18KB
- Forums
- ASX - By Stock
- CSL
- Ann: Notice of Investor/Analyst Briefing 2025 Full Year Result
CSL
csl limited
Add to My Watchlist
2.38%
!
$226.00

Ann: Notice of Investor/Analyst Briefing 2025 Full Year Result
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
$226.00 |
Change
5.260(2.38%) |
Mkt cap ! $109.4B |
Open | High | Low | Value | Volume |
$220.00 | $228.30 | $220.00 | $515.8M | 2.273M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
5 | 121 | $226.00 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$226.01 | 8400 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
5 | 121 | 226.000 |
1 | 175 | 225.950 |
1 | 2 | 225.800 |
1 | 200 | 225.660 |
2 | 41 | 225.650 |
Price($) | Vol. | No. |
---|---|---|
226.010 | 8400 | 1 |
226.500 | 50 | 1 |
226.800 | 40 | 1 |
227.000 | 1074 | 3 |
227.030 | 125 | 1 |
Last trade - 16.12pm 21/08/2025 (20 minute delay) ? |
Featured News
CSL (ASX) Chart |
The Watchlist
NUZ
NEURIZON THERAPEUTICS LIMITED
Michael Thurn, MD & CEO
Michael Thurn
MD & CEO
SPONSORED BY The Market Online